OncoSil Medical Limited (ASX:OSL)
Australia · Delayed Price · Currency is AUD 1.175
+0.025 (2.17%)
Aug 28, 2026, 3:48 PM AEST
OncoSil Medical Market Cap
OncoSil Medical has a market cap or net worth of 36.3 million as of August 28, 2026. Its market cap has increased by 72.15% in one year.
Market Cap
36.30M
Enterprise Value
33.48M
Revenue
5.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.18
ChartMarket Cap Chart
Since August 15, 2005, OncoSil Medical's market cap has increased from 7.29M to 36.30M, an increase of 397.56%. That is a compound annual growth rate of 7.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 36.30M | 98.06% |
| Dec 31, 2025 | 18.33M | -33.55% |
| Dec 31, 2024 | 27.58M | 55.21% |
| Dec 28, 2023 | 17.77M | -60.28% |
| Dec 30, 2022 | 44.74M | 25.48% |
| Dec 31, 2021 | 35.65M | -63.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SomnoMed | 74.49M |
| Cyclopharm | 64.29M |
| Compumedics | 52.94M |
| Cleo Diagnostics | 48.67M |
| HeraMED | 43.98M |
| Nova Eye Medical | 39.88M |
| CleanSpace Holdings | 31.56M |
| Control Bionics | 26.27M |